Partnerships
in Clinical Trials 2008

4th – 7th November, Estrel Convention Centre, Berlin

Event Info

2008 Agenda

2008 Sponsorship

2008 Exhibition

Marketing Tools

Press

Media

Document Downloads

Title	Download
Adrian Otte, Senior Vice President Worldwide Development Operations, PFIZER INC, Experiences With A Strategic Move From Full Service Providers To Functional Service Providers
Barry Overton, Director of Clinical Research Operations, CAMBRIDGE ANTIBODY TECHNOLOGY - Using Earned Value Management in Clinical Research
David Davies, Product Development Director, FUTURA MEDICAL plc - Specific issues for very small sponsor companies
Dr Alan Wood, General Manager, Europe and Asia-Pacific, Covance Clinical and Periapproval Services - Top 5 pitfalls in developing an outsourcing relationship: what are the most common mistakes?
Dave Webber, Clinical Operations Section Head, Procter and Gamble Pharmaceuticals - Managing relationships between sponsor and CRO
David Roblin, Vice President and Head of Research and Development Europe, Pfizer Global research and Development - The Functional Service Provider model is currently delivering for Pfizer and how the strategy will change in the future
Nigel Brooksby, Chairman and Managing Director of sanofi-aventis and President of the ABPI - The state of the British pharmaceutical industry, his plans to boosting pharmaceutical competitiveness in Europe, and the pivotal role of pricing
Simon Weston OBE, National Hero and Inspiration to all - Twenty five years ago, the Sir Galahad was destroyed in Bluff Cove on the Falkland Islands. On board was Simon Weston, Welsh Guardsman
Harold E. Glass Ph.D., Professor of Health Policy, University of the Sciences in Philadelphia and President TTC-llc. Outsourcing: Where is it now and where is it going
Eberhard Weiblen, Managing Director of Porsche Consulting. "Processes designed by Porsche". The optimisation of value creation processes is no longer applicable to production alone.
Interview with Antal Hajos
Is human capital the most important asset a Pharma/Biotech company has? At PCT we asked Graham Belgrave, Vice President, Clinical Operations Development Group, Vernalis R&D Ltd. this very question.
Key outsourcing Governance processes – looking from an out of industry perspective. An interview with Bill Metz, P&G Global Business Services External Business
Udo Breyer, European CRO Manager for Boehringer Ingelheim GmbH thinks about the best way to overcome challenges with these collaborations to make them work for you.
Dr Rob Davie, Vice President and General Manager for EU, Covance Clinical Development talked to us about how Covance has used Six Sigma, and the significant results they have achieved so far.
Scrip - Focus on Partnerships in Clinical Trials

Contact Us

Testimonial

Associate Sponsor

+ Larger Font | + Smaller Font

Designed by Jonathan Ferro | Copyright IIR 2005